Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Gonzalez-Lopez

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Rheumatology International|April 2, 2013
Pulmonary function in ankylosing spondylitis: association with clinical variablesA J L Brambila-Tapia, A D Rocha-Muñoz, L Gonzalez-Lopez, et al.
Scandinavian Journal of Rheumatology|May 25, 2016
Association between bone turnover markers, clinical variables, spinal syndesmophytes and bone mineral density in Mexican patients with ankylosing spondylitisJ I Gamez-Nava, L F de la Cerda-Trujillo, M L Vazquez-Villegas, et al.
Inflammopharmacology|September 14, 2018
Serum P-glycoprotein level: a potential biomarker of DMARD failure in patients with rheumatoid arthritisE E Perez-Guerrero, L Gonzalez-Lopez, J F Muñoz-Valle, et al.
Biomed Research International|October 15, 2016
The -174G/C Interleukin-6 Gene Promoter Polymorphism as a Genetic Marker of Differences in Therapeutic Response to Methotrexate and Leflunomide in Rheumatoid ArthritisA J Ruiz-Padilla, J I Gamez-Nava, A M Saldaña-Cruz, et al.
Genetics and Molecular Research : GMR|December 22, 2016
Association between -174G/C and -572G/C interleukin 6 gene polymorphisms and severe radiographic damage to the hands of Mexican patients with rheumatoid arthritis: a preliminary reportS A Zavaleta-Muñiz, L Gonzalez-Lopez, J D Murillo-Vazquez, et al.
Rheumatology International|January 13, 2012
Prescription for antiresorptive therapy in Mexican patients with rheumatoid arthritis: is it time to reevaluate the strategies for osteoporosis prevention?J I Gamez-Nava, S A Zavaleta-Muñiz, M L Vazquez-Villegas, et al.
Journal of Immunology Research|August 1, 2017
Polymorphism rs2073618 of the <i>TNFRSF11B</i> (<i>OPG</i>) Gene and Bone Mineral Density in Mexican Women with Rheumatoid ArthritisC A Nava-Valdivia, A M Saldaña-Cruz, E G Corona-Sanchez, et al.
Biomed Research International|September 9, 2021
Assessment of Serum sRANKL, sRANKL/OPG Ratio, and Other Bone Turnover Markers with the Estimated 10-Year Risk of Major and Hip Osteoporotic Fractures in Rheumatoid Arthritis: A Cross-Sectional StudyC A Nava-Valdivia, J M Ponce-Guarneros, A M Saldaña-Cruz, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Rheumatology International|April 2, 2013
Pulmonary function in ankylosing spondylitis: association with clinical variablesA J L Brambila-Tapia, A D Rocha-Muñoz, L Gonzalez-Lopez, et al.
Scandinavian Journal of Rheumatology|May 25, 2016
Association between bone turnover markers, clinical variables, spinal syndesmophytes and bone mineral density in Mexican patients with ankylosing spondylitisJ I Gamez-Nava, L F de la Cerda-Trujillo, M L Vazquez-Villegas, et al.
Inflammopharmacology|September 14, 2018
Serum P-glycoprotein level: a potential biomarker of DMARD failure in patients with rheumatoid arthritisE E Perez-Guerrero, L Gonzalez-Lopez, J F Muñoz-Valle, et al.
Biomed Research International|October 15, 2016
The -174G/C Interleukin-6 Gene Promoter Polymorphism as a Genetic Marker of Differences in Therapeutic Response to Methotrexate and Leflunomide in Rheumatoid ArthritisA J Ruiz-Padilla, J I Gamez-Nava, A M Saldaña-Cruz, et al.
Genetics and Molecular Research : GMR|December 22, 2016
Association between -174G/C and -572G/C interleukin 6 gene polymorphisms and severe radiographic damage to the hands of Mexican patients with rheumatoid arthritis: a preliminary reportS A Zavaleta-Muñiz, L Gonzalez-Lopez, J D Murillo-Vazquez, et al.
Rheumatology International|January 13, 2012
Prescription for antiresorptive therapy in Mexican patients with rheumatoid arthritis: is it time to reevaluate the strategies for osteoporosis prevention?J I Gamez-Nava, S A Zavaleta-Muñiz, M L Vazquez-Villegas, et al.
Journal of Immunology Research|August 1, 2017
Polymorphism rs2073618 of the <i>TNFRSF11B</i> (<i>OPG</i>) Gene and Bone Mineral Density in Mexican Women with Rheumatoid ArthritisC A Nava-Valdivia, A M Saldaña-Cruz, E G Corona-Sanchez, et al.
Biomed Research International|September 9, 2021
Assessment of Serum sRANKL, sRANKL/OPG Ratio, and Other Bone Turnover Markers with the Estimated 10-Year Risk of Major and Hip Osteoporotic Fractures in Rheumatoid Arthritis: A Cross-Sectional StudyC A Nava-Valdivia, J M Ponce-Guarneros, A M Saldaña-Cruz, et al.
Pageof 3